EUVIMEDEUVIMED entdecken
Crossref

Papaverine ameliorates psoriasis-like skin inflammation by regulating immune cell differentiation and RAGE–S100A7 axis in an imiquimod-induced murine model

Nontaphat Leerach, Yupa Srithongchai, Seiichi Munesue, Kumi Kimura, Yu Oshima, Ai Harashima, Hisanori Goto, Mariko Tanaka, Pathitta Sakulsak, Hiroya Takahashi, Takahiro Ishimoto, Yoshimichi Sai und 1 weitere

The Journal of Immunology · 2026

DOI: 10.1093/jimmun/vkag233 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Immunology, 2026. Verfasst von Nontaphat Leerach und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Vascular Biology, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan. Hauptthemen laut MEDLINE: Psoriasis, Papaverine, Receptor for Advanced Glycation End Products, S100 Proteins. Die Arbeit nennt 51 Literaturangaben. Gefördert von: Ministry of Education, Culture, Sports, Science and Technology, Japan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Psoriasis is a chronic, immune-mediated inflammatory skin disease affecting at least 2% of the global population. Papaverine, an alkaloid with known anti-inflammatory, anti-cancer, and RAGE-antagonistic properties, has not been previously evaluated for anti-psoriatic activity. This study investigated the protective effects and mechanisms of papaverine in an imiquimod (IMQ)–induced psoriasis-like model in BALB/c mice. Papaverine treatment significantly ameliorated clinical symptoms, as evidenced by reductions in psoriatic lesions, skin thickness, severity index scores, T- and B-cell infiltration, and cutaneous angiogenesis. It also downregulated IMQ-induced mRNA expression of keratinocyte differentiation markers Krt10 and Ivl. Flow cytometric analysis revealed a marked reduction in B220⁺CD138⁺ plasmablasts and B220⁻CD138⁺ plasma cells in both circulation and spleen. These effects were associated with modulation of key transcription factors involved in plasma cell differentiation, including Prdm1, Xbp1, and Bcl6. Notably, the population of CD3⁺CD4⁻CD8⁻ double-negative T cells was also decreased following papaverine administration. Inflammatory cytokine and chemokine mRNA levels in IMQ-exposed skin—namely Il1b, Il6, Ifng, Mcp1, Il22, S100a7, and Ager—were significantly suppressed. These findings suggest that papaverine ameliorates psoriasis-like symptoms through inhibition of proinflammatory cytokines and suppression of aberrant plasma cell differentiation. In conclusion, papaverine demonstrates therapeutic potential as a candidate for the treatment of psoriasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PsoriasisPapaverineReceptor for Advanced Glycation End ProductsS100 ProteinsSkinAnimalsImiquimodMiceCell DifferentiationMice, Inbred BALB CDisease Models, AnimalAminoquinolinesFemalePlasma Cells

Stichwörter der Autor:innen

anti-psoriaticchronic inflammationpapaverineplasma cell differentiationpsoriasis

Substanzen

ImiquimodPapaverineReceptor for Advanced Glycation End ProductsS100 ProteinsAminoquinolines

Autor:innen und Institutionen

  • Department of Biochemistry and Molecular Vascular Biology, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.
  • Princess Srisavangavadhana Faculty of Medicine, Chulabhorn Royal Academy, Bangkok, Thailand.
  • Research Center on Clinical and System Microbiology, Chulabhorn Royal Academy, Bangkok, Thailand.
  • Department of Clinical Pharmacokinetics, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.
  • Department of Hospital Pharmacy, University Hospital, Kanazawa University, Kanazawa, Japan.

ORCID-Profile: Yasuhiko Yamamoto

Förderung

  • Ministry of Education, Culture, Sports, Science and Technology, Japan

Zitieren

APA

Leerach, N., Srithongchai, Y., Munesue, S., Kimura, K., Oshima, Y., Harashima, A., Goto, H., Tanaka, M., Sakulsak, P., Takahashi, H., Ishimoto, T., Sai, Y., & Yamamoto, Y. (2026). Papaverine ameliorates psoriasis-like skin inflammation by regulating immune cell differentiation and RAGE–S100A7 axis in an imiquimod-induced murine model. The Journal of Immunology. https://doi.org/10.1093/jimmun/vkag233

Vancouver

Leerach N, Srithongchai Y, Munesue S, Kimura K, Oshima Y, Harashima A, et al. Papaverine ameliorates psoriasis-like skin inflammation by regulating immune cell differentiation and RAGE–S100A7 axis in an imiquimod-induced murine model. The Journal of Immunology. 2026. doi:10.1093/jimmun/vkag233

BibTeX
@article{Leerach2026,
  author = {Leerach, Nontaphat and Srithongchai, Yupa and Munesue, Seiichi and Kimura, Kumi and Oshima, Yu and Harashima, Ai and Goto, Hisanori and Tanaka, Mariko and Sakulsak, Pathitta and Takahashi, Hiroya and Ishimoto, Takahiro and Sai, Yoshimichi and Yamamoto, Yasuhiko},
  title = {Papaverine ameliorates psoriasis-like skin inflammation by regulating immune cell differentiation and RAGE–S100A7 axis in an imiquimod-induced murine model},
  journal = {The Journal of Immunology},
  year = {2026},
  doi = {10.1093/jimmun/vkag233}
}
Kostenlos starten →